http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2706500-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b462d01b78ebdce6a76c20f25a1b2c6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B8-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B8-13 |
| filingDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6e1f43aead5951ebd87327b7070bae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a70c0635a924c8bcf171f8326804740a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52503dc1cad25fac6270175a8e6bbb9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f226c6988ea9d432f9911ef873cdeecb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b34e089552c4ac734022a5e4bd5166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4cf588097eeee165d15d82c48b578a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f94ae099bead2dbac12b6ec366d009b6 |
| publicationDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2706500-C1 |
| titleOfInvention | Method for assessing the risk of disturbed hormone-forming function directly in the thyroid gland |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to endocrinology. To assess the risk of disturbing the hormone-forming function directly in the thyroid gland, ultrasonography of the thyroid gland, blood serum level of thyrotropic hormone of the hypophysis and free thyroxine level, structural changes in the thyroid are assessed taking into account the results of thyroid ultrasonography. That is followed by an X-ray computed tomography of the thyroid gland with determination of its density in units of Hounsfield density (HU) and if its density is below 85 units according to Hounsfield (HU), presence or risk of developing thyroid dysfunction caused by iodine deficiency with prescription in treating iodine preparations, and if the thyroid density is more than 140 units according to Hounsfield HU, the presence or risk of developing thyroid dysfunction caused by excess iodine intake, which excludes iodine-containing drugs in treating. n EFFECT: method enables fast and effective detection of hormone-forming function disorders directly in the thyroid gland. n 1 cl, 2 ex |
| priorityDate | 2019-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.